Association Between Sarcopenic Obesity and Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis.
Obesity
metabolic syndrome
overweight
reduced lean body mass
sarcopenia
sarcopenic obesity.
Journal
Current cardiology reviews
ISSN: 1875-6557
Titre abrégé: Curr Cardiol Rev
Pays: United Arab Emirates
ID NLM: 101261935
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
12
2019
revised:
21
01
2020
accepted:
06
02
2020
pubmed:
15
2
2020
medline:
28
7
2020
entrez:
15
2
2020
Statut:
ppublish
Résumé
In the last two decades, a new phenotype termed Sarcopenic Obesity (SO), in which sarcopenia and obesity coexist, has emerged. The aim of this systematic review and meta-analysis was first to assess the prevalence of Metabolic syndrome (Mets) among individuals with and without SO, and second, to determine if SO may increase the relative risk of Mets. This study was conducted in adherence to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines and the data were collated by means of metaanalysis and narrative synthesis. Twelve studies including a total of 11,308 adults with overweight or obesity of both genders met the inclusion criteria and were reviewed, revealing two main findings. First, a similar overall prevalence of Mets in individuals with SO (61.49%; 95% CI: 52.19-70.40) when compared to those without SO (56.74%; 95% CI: 47.32-65.93) was identified. Second, the presence of SO appears not to increase the risk of Mets with respect to those without SO (RR = 1.08, 95% CI: 0.99- 1.17, p = 0.07). No higher prevalence of Mets among individuals with SO when compared to those with obesity only, nor a significant association between SO and a higher risk of Mets was found.
Sections du résumé
BACKGROUND
BACKGROUND
In the last two decades, a new phenotype termed Sarcopenic Obesity (SO), in which sarcopenia and obesity coexist, has emerged.
OBJECTIVE
OBJECTIVE
The aim of this systematic review and meta-analysis was first to assess the prevalence of Metabolic syndrome (Mets) among individuals with and without SO, and second, to determine if SO may increase the relative risk of Mets.
METHODS
METHODS
This study was conducted in adherence to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines and the data were collated by means of metaanalysis and narrative synthesis.
RESULTS
RESULTS
Twelve studies including a total of 11,308 adults with overweight or obesity of both genders met the inclusion criteria and were reviewed, revealing two main findings. First, a similar overall prevalence of Mets in individuals with SO (61.49%; 95% CI: 52.19-70.40) when compared to those without SO (56.74%; 95% CI: 47.32-65.93) was identified. Second, the presence of SO appears not to increase the risk of Mets with respect to those without SO (RR = 1.08, 95% CI: 0.99- 1.17, p = 0.07).
CONCLUSION
CONCLUSIONS
No higher prevalence of Mets among individuals with SO when compared to those with obesity only, nor a significant association between SO and a higher risk of Mets was found.
Identifiants
pubmed: 32056530
pii: CCR-EPUB-104503
doi: 10.2174/1573403X16666200214104122
pmc: PMC7460704
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
153-162Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Références
Arch Gerontol Geriatr. 2014 Jul-Aug;59(1):56-61
pubmed: 24766993
Exp Gerontol. 2018 Jul 15;108:99-105
pubmed: 29649572
JAMA. 2018 Jan 23;319(4):388-396
pubmed: 29362800
Endocr J. 2014;61(1):61-70
pubmed: 24088600
World J Diabetes. 2019 May 15;10(5):311-323
pubmed: 31139318
Clin Nutr. 2018 Dec;37(6 Pt A):1787-1793
pubmed: 29857921
J Nutr Health Aging. 2016;20(9):958-963
pubmed: 27791227
Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):693-700
pubmed: 18827572
Endocrinol Metab (Seoul). 2013 Jun;28(2):86-9
pubmed: 24396659
Diabet Med. 2016 Aug;33(8):1052-9
pubmed: 26479063
Curr Opin Endocrinol Diabetes Obes. 2013 Oct;20(5):412-9
pubmed: 23974769
BMC Med. 2011 May 05;9:48
pubmed: 21542944
J Aging Health. 2012 Aug;24(5):812-26
pubmed: 22451528
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Korean J Intern Med. 2016 Nov;31(6):1054-1060
pubmed: 27809450
Appl Physiol Nutr Metab. 2009 Feb;34(1):18-24
pubmed: 19234581
Clin Endocrinol (Oxf). 2013 Apr;78(4):525-32
pubmed: 22563924
Indian J Dermatol. 2016 May-Jun;61(3):261-4
pubmed: 27293245
Obesity (Silver Spring). 2016 Feb;24(2):526-34
pubmed: 26813531
BMC Med Inform Decis Mak. 2007 Jun 15;7:16
pubmed: 17573961
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
J Am Soc Hypertens. 2013 Nov-Dec;7(6):420-5
pubmed: 23910010
Hormones (Athens). 2018 Sep;17(3):321-331
pubmed: 30014320
J Bone Metab. 2017 Feb;24(1):9-14
pubmed: 28326296
ACP J Club. 1995 Nov-Dec;123(3):A12-3
pubmed: 7582737
Obes Facts. 2018;11(4):294-305
pubmed: 30016792
Diabetes Care. 2010 Jul;33(7):1652-4
pubmed: 20460442
Neurol India. 2015 Nov-Dec;63(6):1006-7
pubmed: 26588658
Clin Nutr. 2014 Aug;33(4):668-72
pubmed: 24074549
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Curr Diabetes Rev. 2020;16(4):376-380
pubmed: 31663844
Nutr Metab Cardiovasc Dis. 2013 Jun;23(6):511-8
pubmed: 22397879
J Am Med Dir Assoc. 2017 Apr 1;18(4):312-319
pubmed: 27914851
Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):270-8
pubmed: 23079031
J Endocrinol Invest. 2014 Mar;37(3):247-60
pubmed: 24615361
J Korean Med Sci. 2012 Jul;27(7):748-55
pubmed: 22787369
Indian J Sex Transm Dis AIDS. 2010 Jan;31(1):47-50
pubmed: 21808439
Clin Transplant. 2015 Mar;29(3):211-5
pubmed: 25594826
Nutr Hosp. 2016 Sep 20;33(5):592
pubmed: 27759996